Cerrahpaşa Medical Journal
LETTER TO THE EDITOR

The Use of High-Dose Omalizumab in the Treatment of Resistant Chronic Urticaria: A Case Series

1.

Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye

Cerrahpasa Med J 2025; 49: 1-2
DOI: 10.5152/cjm.2025.25012
Read: 25 Downloads: 7 Published: 28 March 2025

Cite this article as: Ferhatoğlu ZA, Uzunçakmak TK, Mutlu G. The use of high-dose omalizumab in the treatment of resistant chronic urticaria: a case series. Cerrahpaşa Med J. 2025, 49, 0012, doi: 10.5152/cjm.2025.25012

Files
EISSN 2687-1904